Optical Gene Therapy Drug Therapy

FDA approves 1st gene therapy for genetic hearing loss

FDA approves first gene therapy for genetic hearing loss

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss.

· 1d · on MSN

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

· 1d · on MSN

Regeneron wins FDA approval for first gene therapy for genetic hearing loss

· 14h

Regeneron FDA approval: gene therapy for inherited deafness free

The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and Regeneron said it will make the treatment available at no cost to eligible patients...

· 1d

'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness

· 1d

FDA approves Regeneron’s hearing loss gene therapy

STAT

Gene therapy trial for deafness adds evidence to drug’s efficacy

After gene therapy for a rare form of deafness, 90% of participants in a clinical trial in China had significant improvement in hearing.

Hosted on MSN

New gene therapy drugs can save lives, but many cost millions

A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there's a catch. Many cost millions of dollars for a single dose. And American health care hasn't figured out how to pay.